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Objective: To develop a modified model for experimental infective endocarditis (IE) in the rat. The goal was to induce 
a primary infectious focus in the temporomandibular joint (TMJ) of a rat. Hematogenous translocation of the bacteria 
to the traumatized aortic valve was desired. 
Methods: Catheterization of the right carotid artery through the aortic valve was performed 7 days after induction of 
arthritis, which was done by intra-articular injection of glucocorticosteroid (triamcinolone acetonide, 1 mg) and intra- 
venous challenge with lo7 CFU Staphylococcus aureus. 
Results: TMJ arthritis could be induced by intra-articular triamcinolone acetonide followed by intravenous bacterial 
challenge. Joints not given glucocorticosteroid were not affected. Only rats with arthritis developed IE subsequent to 
catheterization as a result of bacteremia generated from the arthritis. 
Conclusions: The present model may serve as a complement to the conventional method for induction of IE, in which 
a high intravenous challenge has to be given. In the present model, IE was instead the result of a continuous low level 
of bacteremia from an infectious focus in the TMJ. This model mimics the natural development of IE in patients, and 
may assist as a setting for prophylactic and therapeutic trials. 
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Staphylococci are responsible for a large proportion of 
cases of septicemia, endocarditis and arthritis. Despite 
progress in medicine, microbiology and the develop- 
ment of new antimicrobial agents, these diseases may 
still be life-threatening conditions with high morbidity 
and even mortality. The situation is becoming more 
complex with the emergence of multiresistant strains of 
staphylococci in hospitals throughout the world. 
Hematogenously acquired bacterial arthritis is a 
serious medical problem. This rapidly progressive and 
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highly destructive disease is difficult to treat, with less 
than 50% of the infected patients recovering without 
serious joint damage. Long-term oral or intra-articular 
corticosteroids or other immunosuppressive agents are 
probably important factors in the promotion of bacterial 
arthritis. Intra-articular corticosteroids implement their 
anti-inflammatory effect by genetic downregulation 
of several pro-inflammatory proteins. In general, the 
effect of corticosteroids on leukocyte circulation is 
more profound than that on cellular immunity, with 
humoral immunity being least affected [l]. Staphylo- 
coccus aureus is the most common etiologic agent of 
bacterial arthritis, causing up to 80% of such cases [2,3]. 
The synovium is highly vascularized and contains no 
limiting basement membrane, thus promoting easy 
access of blood contents to the synovial space. Bacteria 
may also directly infect a joint, e.g. from a deeply 
penetrating wound, contiguous osteomyelitis rupturing 
into the joint, but may also be introduced by arthro- 
scopy or open surgery [4-71. 
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An infection of a joint may function as a primary 
infectious focus and may be responsible for the spread 
of the infection by the slow release of bacteria into the 
bloodstream, causing septicemia and endocarditis in 
patients at risk. 
An animal model of this type of secondary spread 
of infections mimics the clinical situation when a 
contagious focus leads to a systemic infection. This 
model could be useful when studying the initiating 
events of the infection, such as bacterial adherence and 
other virulence factors, in an experimental system. 
Studies of the natural history of intravascular infections 
[8-141 have mainly been conducted in rats and rabbits. 
All these studies have been performed according to 
conventional techniques, which require an intravenous 
challenge of microorganisms for direct establishment of 
the infection. 
In this report, we describe a modified rat model of 
catheter-induced endocarditis which is secondary to 
temporomandibular joint (TMJ) arthritis induced by 
intra-articular injection of triamcinolone acetonide 
followed by intravenous challenge with S. aureus. We 
have induced arthritis and investigated the hemato- 
genous translocation of the primary infection to the 
aortic valve. 
This model of endocarditis mimics the natural 
pathway of endocarditis better than the conventional 
method, where a high intravenous challenge dose of 
microorganisms for direct valvular infection has to be 
given. 
MATERIALS AND METHODS 
Rats 
Female pathogen-free Wistar rats weighing approxi- 
mately 185 g were used in this study. They were fed 
laboratory chow and water ad libitum under standard 
conditions of temperature and light, and were housed 
five per cage. 
Bacterial strain and culture conditions 
S. aureus strain Phillips was used for infection [15]. 
Bacteria were cultured in Luria-Bertani (LB) medium 
overnight at 37"C, and then washed in phosphate- 
buffered saline (PBS), adjusted to the desired concen- 
tration and kept in aliquots at -70°C. The viable count 
was determined before freezing at -70°C and prior to 
each experiment. The same batch of strain Phillips was 
used for all experiments. 
induction of septic arthritis of the T M J  
The rats were anesthetized by intramuscular injection 
of 0.5 mL/kg fentanyl citrate (0.315 mg/mL) and 
0.5 mL/kg of fluanisone (10 mg/mL) (Hypnorm, 
Janssen, Animal Health, Division ofJanssen-Cilag LTD, 
Saunderton, High Wycombe, UK) per kilogram. 
Under aseptic conditions, 0.1 mL of triamcinolone 
acetonide was administered by intra-articular injection 
into one of the TMJs. The contralateral joint was 
always used as control and received 0.1 mL of physio- 
logic saline. After insertion of triamcinolone acetonide 
and saline, the rats were intravenously challenged with 
1.0 mL of S. aureus (Phillips). All procedures were 
carried out under aseptic conditions. The rats were 
weighed and clinically examined daily for 1 week. 
The overall clinical condition was evaluated, with 
assessment of weight, general appearance, alertness, and 
skin abnormalities of each rat. Arthritis was defined as 
visible joint swelling or erythema of the infected joint 
or in conjunction with a subsequent positive 
microbiological analysis from TMJ specimens. 
Optimization of variables for induction of arthritis 
The optimal sampling day was determined by using 14 
rats, divided into four groups, receiving 0.01 mg of 
triamcinolone acetonide (0.1 mL) and lo7 colony- 
forming units (CFU) of Phillips (1.0 mL). The animals 
were sacrificed on days 4 (n=4), 8 (n=5), 12 (n=5) and 
15 (n=5). The TMJs and the spleen were aseptically 
removed for microbiological analysis. 
The optimal dose of triamcinolone needed to 
produce the necessary conditions to facilitate hemato- 
genous arthritis without causing severe clinical effects 
in non-infected animals was estimated in a pilot 
experiment. Five groups of 15 animals each were given 
an intra-articular injection into the TMJ with 0.1 mL 
containing 1, 0.1, 0.01, 0.001 or 0 mg triamcinolone 
acetonide, respectively. The contralateral joint was used 
as control, receiving 0.1 mL of PBS intra-articularly. All 
animals were then intravenously challenged with lo7 
CFU of strain Phillips (1.0 mL). 
Another group of five animals received 1 mg 
of triamcinolone acetonide (0.1 mL) intra-articularly 
without any bacterial challenge to allow the study the 
clinical systemic effect of the highest dose used in the 
experiment. 
The optimal challenge dose of S. aureus was 
determined by giving 42 rats 1 mg of triamcinolone 
acetonide intra-articularly (0.1 mL) (which was found 
to be the optimal dose in the pilot test described). 
Thirteen rats were given lo5, 14 rats were given l o 6  
and 15 rats were given 10' CFU of strain Phillips. The 
contralateral joint was used as control receiving 0.1 mL 
of PBS intra-articularly. The rats were observed clini- 
cally for 2 weeks and were then killed for microbio- 
logical sampling. 
The percentage weight change subsequent to arth- 
ritis was determined, using 18 animals divided into two 
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groups. Animals in both groups were infected with lo7 
CFU of Phillips (1.0 mL). Animals in one group were 
also injected with 1 .O mg triamcinolone acetonide intra- 
articularly, whereas the control group was not given 
corticosteroid. 
Estimation of bacteremia induced by arthritis was 
done by collecting blood samples from the carotid 
artery 6 days (three rats), 7 days (four rats) and 8 days 
(three rats) after induction of arthritis. The samples 
were serially diluted and cultured on blood agar plates 
for 24 h at 37°C. 
Endocarditis, secondary to arthritis 
Seven days post-challenge, sterile aortic vegetations 
were induced in the rats by introducing a polyethylene 
catheter through the right carotid artery as described 
previously [8,16]. After 24 h with the catheter left 
in place, the animals were killed. The right and left 
TMJs, aortic valvular vegetations and the spleen were 
aseptically removed for microbiological analysis. 
Vegetations and spleens were homogenized with a 
teflon homogenizer in sterile saline. The homogenized 
tissues were then serially diluted in saline and plated 
onto blood agar plates and cultured for 24 h at 37°C. 
The TMJs were homogenized by vigorous vortexing 
with glass beads, diluted serially and plated onto blood 
agar plates. Numbers of CFU per piece of extirpated 
tissue were expressed as loglo. Detection level was 2 
CFU per piece of tissue. Endocarditis was defined as 
aortic vegetations with positive microbiological growth. 
Arthritis was induced in 11 rats by intra-articular 
injection of 1 mg of triamcinolone acetonide and 
intravenous challenge by lo7 CFU of S. aureus. On 
day 7, seven rats with established TMJ arthritis were 
catheterized via the carotid artery in order to induce 
vegetations on the aortic valve. Another four rats with 
arthritis were used as controls without catheterization. 
Samples from all the animals were taken 24 h later. 
Statistical methods 
Statistical comparisons of proportions were made by 
the chi-square test. All values of log CFU are reported 
as the mean k standard deviation (SD). 
RESULTS 
Optimization of variables for induction of arthritis 
The optimal timing for catheterization was determined 
(data not shown) to be 7 days after application of 
triamcinolone acetonide and bacterial challenge, signs 
of arthritis being at a maximum by day 7. It was also 
observed that after a period of 2 weeks, the affected 
animals began to recover from the infection and started 
to regain weight (data not shown). TMJs affected with 
arthritis displayed abscess formation involving bone 
tissue and a typical pathologic appearance. 
To determine the optimal dose of triamcinolone 
acetonide, 60 rats were studied and, based on the rate 
of arthritis, 1 mg of triamcinolone acetonide was the 
dose chosen for further studies. The contralateral control 
joints remained intact (Table 1). 
Eight animals, which were not given triam- 
cinolone acetonide, did not develop TMJ arthritis. No 
signs of TMJ arthritis were found in animals ( n = 3 )  
Table 1 Infection rates with various doses of triamcinolone acetonide 
Dose Steroid-treated TMJa Control TMJ Spleen 
(mg) (no. of rats) (log CFU/tissue) (log CFU/tissue) (log CFUItissue) 
~~ 
1.0 (n=15) 14/15 (5.6f1.8) 3/15 (2.7k1.0) 12/15 (3.5k1.6) 
0.1 (n=15) 3/15 (3.7f2.4) 0/15 (0-0) 2/15 (2.5t1.44) 
0.01 (n=15) 2/15 (3.6k1.8) 0/15 (O+O) 4/15 (1.3k0.8) 
0.001 (n=15) 0/15 ( O f O )  0/15 (020) 2/15 (2.5t1.4) 
"Number of animals infected per total. 
Mean values and SEs of log CFU/tissue are shown in parentheses 
Table 2 Infection rates with various challenge doses 
Challenge dose Steroid-treated TMJa Control TMJ Spleen 
(log CFU) (no. of rats) (log CFU/tissue) (log CFU/tissue) (log CFU/tissue) 
105 (@=i3) 7/13 (6.3t0.9) 2/13 (2.120.2) 5/13 (4.651.5) 
lo6 (n=14) 9/14 (6.6k0.8) 3/14 (3.1f0.7) 12/14 (4.4k2.1) 
107 (,,=is) 14/15 (5.6f1.8) 3/15 (2.721.0) 12/15 (3.5k1.6) 
"Number of animals infected per total. 
Mean values and SEs of log CFU/tissue are shown in parentheses 
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receiving only triamcinolone acetonide (1 mg) but no 
bacterial challenge (data not shown). 
Forty-two rats were used in order to establish the 
optimal challenge dose. Based on the rate of infection 
(infection dose90-95), lo7 CFU was the dose chosen for 
further studies (Table 2). The contralateral control 
joints had significantly lower rates of infection ( p <  0.05) 
and fewer bacteria were recovered compared to the 
infected rats. 
All the animals lost weight postoperatively due to 
anesthesia. A comparison of percentage weight change 
showed that animals with active arthritis kept losing 
weight until days 12-13, whereas control animals that 
were only anesthetized regained weight from the 
second day (data not shown). For example, at day 7, 
animals with septic arthritis (n=8)  lost 23% weight as 
compared with control animals (n= 10) receiving only 
bacteria but no corticosteroid (p<O.OOOl). 
Blood cultures 
In a separate experiment, blood samples were taken on 
days 6, 7 and 8 after induction of septic arthritis from 
10 animals. Eight of these rats were blood culture 
positive (Figure 1). The amount of bacteria in the 10 
animals varied from 0 to 103.5 bacteria per mL ofblood. 
Nine of these animals developed arthritis in the 
corticosteroid-treated TMJs. No correlations between 
the quantity of bacteria in the affected TMJ, or the 
severity of the arthritis, and the amount of bacteria in 
the blood were found. 
Nine of the spleens yielded positive cultures. One 
rat did not show any signs of either septicemia or 
arthritis. 
Endocarditis 
Arthritis was induced in 11 rats by 1 mg of steroid and 
a challenge dose of lo7 CFU. Seven of these were 
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Figure 1 Log number of bacteria/mL blood for each 
animal, 6 (n=3), 7 (n=4), and 8 (n=3) days after induction 
of septic arthritis. 
7 8l T 
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Figure 2 Log number of total bacteria recovered from 
both TMJs, spleen and aortic valve 24 h post- 
catheterization and 8 days post-challenge with lo7 CFU of 
Phillips and 1 mg intra-articular injection of triamcinolone 
acetonide. Bars indicate mean values 2 SD. 
catheterized on day 7 and all of these developed 
endocarditis as defined by positive bacterial growth on 
aortic valvular vegetations. In only two of the rats were 
the contralateral joints infected. Four rats with arthritis 
which were not catheterized did not develop endo- 
carditis. Figure 2 shows the log number of total CFU 
recovered from joints, aortic valves and spleens. 
DISCUSSION 
Intra- and periarticular corticosteroids for treatment of 
a variety of rheumatic diseases have been used for 
nearly 50 years, yet publications that have carefully 
examined the mechanisms of action, the pharmaco- 
kinetics and the comparative safety and efficacy of 
the available agents are sparse. Highly branched esters 
of triamcinolone or methylprednisolone are the 
preferred agents. Pharmacokinetic studies reveal that 
triamcinolone hexacetonide, the least soluble of all the 
corticosteroid esters, is retained in the joint for 2-3 
weeks [17]. 
Corticosteroids have been shown to inhibit the 
synthesis of prostaglandins [ 18-20]. Glucocortico- 
steroids are therefore potent anti-inflammatory agents. 
Glucocorticoids also inhibit leukocyte accumulation 
and plasma exudation at  sites of inflammation. Neutro- 
phi1 adhesion to endothelial cells is blocked by these 
drugs, resulting in decreased trapping of neutrophils at 
inflammatory sites and peripheral blood neutrophilia. 
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A recent study performed by Verdrengh and Tarkowski 
emphasized the crucial protective role of neutrophils 
in the early phase of S. aureus infection [21]. Gluco- 
corticoids have a variety of effects on other inflam- 
matory cells, including macrophages, mast cells, and 
eosinophils [ 11. 
The aim of this study was to develop a modified 
model of endocarditis secondary to septic arthritis in 
the rat. A glucocorticoid was given intra-articularly in 
the TMJ, followed by intravenous challenge with 
bacteria. Once the septic arthritis was established, on 
day 7, rats were catheterized for 24 h to induce valvular 
vegetations, and, in combination with the bacteremia 
caused by the septic condition, endocarditis resulted in 
all seven rats studied. In a separate experiment it was 
shown that eight of nine rats with septic arthritis indeed 
become bacteremic. In the conventional model of 
endocarditis, catheterization is done on day 0, chal- 
lenge on day 1 and sampling at 12 h or later after 
challenge [16,22,23]. We have in a previous publication 
[22] reported that no difference in recovered CFU was 
found with the catheter taken out or left in place at the 
time of challenge, i.e. on day 1. Non-catheterized rats 
did not get endocarditis in this study. As in the conven- 
tional model of endocarditis, valvular vegetations thus 
represent a prerequisite for endocarditis to develop. 
In the conventional model of rat endocarditis, we 
have previously found an ID50 at a challenge dose of 
104-105 CFU per animal. This is in agreement with 
observations by others [24,25]. In the study presented 
here, in eight of 10 animals with septic arthritis, 
bacteremia was detected at days 6 ,7  and 8 and the level 
of bacteremia was limited to 10°.5-103.5/mL blood. 
This level of bacteremia led to 100% endocarditis in a 
group of seven. We therefore conclude that the con- 
tinuity, despite the low level, of bacteremia leads to 
endocardh 
We have also noted previously [22] that when lo6 
-lo7 CFU were given, between and 102.5 CFU 
could be recovered from the aortic valves 1 h after 
bacteria were given, and that no bacteria were left in 
circulation (unpublished finding). This means that only 
l/104.5 CFU, adheres during the first hour post- 
challenge. Consequently, at the IDSO dose of lo4-lo5, 
very few bacteria attached to the valves are required for 
endocarditis. The limited numbers of bacteria in the 
bloodstream in the present model adhere to the vege- 
tations either due to a higher adherence propensity or 
due to the longer time involved with constant generation 
of bacteremia, as compared with the situation in the 
conventional model. 
Two of the contralateral joints (2/7) in the endo- 
carditis experiment were shown to be infected but 
without clinical symptoms. The medical status of these 
animals indicated a general bacteremia involving most 
tissues and organs, including the control joints. 
It should also be emphasized that the bacterial 
growth conditions in this model are different &om the 
conditions in the conventional method of infective 
endocarditis. The bacteria giving rise to endocarditis in 
this model have multiplied under in vivo conditions. 
The establishment of the primary infection, septic arth- 
ritis, allows in vivo passage of the bacteria, in contrast 
to the case in the original model, where the bacteria 
are grown in vitro prior to challenge. The interaction 
between a host and a microbe during pathogenesis is a 
dynamic process. The infecting organism encounters 
diverse environmental conditions during its transition 
from an external reservoir to a host, as well as during 
the infectious process within the host. To be able to 
survive at various locations, the bacteria must be able 
to control the expression of essential features. The set 
of virulence factors that are required for survival at one 
location may confer severe disadvantages in another 
environment [26]. 
S. aureus is the most common organism causing 
septic arthritis in humans and one of the most im- 
portant pathogens for the development of endocarditis. 
For experimental models of infectious arthritis, small 
animals have been selected because of convenience and 
In conclusion, we have developed a new model of 
septic arthritis and modified the model of endocarditis 
in the rat. The combination of the two models enables 
the investigator to explore unanswered questions con- 
cerning the initiating events of the infection, such as 
bacterial adherence and the role of other virulence 
factors required for the translocation of infection from 
one site to another. The important aspects of the new 
model of endocarditis can be summarized as follows: 
(1) endocarditis is caused by bacteria generated by a 
primary infection, not by the challenge itself; ( 2 )  
bacteria causing endocarditis are cultivated in vivo, not 
in vitro; (3) a lower bacteremic level is sufficient; and 
(4) bacteremia and development of catheter-induced 
vegetations are simultaneous, whereas in the conven- 
tional model, vegetations are induced first, followed by 
bacterial challenge. 
cost. 
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